HER2+ 유방암

1개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1 programs
CGTStandard DatabasestaleMerck Sharp & Dohme LLCPhase 3

Recombinant Interferon Alfa-2b (Recombinant Interferon Alfa-2b)

Recurrent Melanoma; Stage IIIA Cutaneous Melanoma AJCC v7 · HER2

#HER2#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 83Status Recruiting